A decrease in NGF level has been observed in the serum of PD models [104,105], and NGF infusion has been pursued in a single PD patient to support adrenal chromaffin tissue engrafted in the patient’s putamen [106,107]. This evidence concerns the gene NGF and Parkinson disease.